Clinical Trials in Cáceres, Caceres
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Recurrent Ovarian CancerFolate Receptor-Alpha Positive
AbbVie100 enrolled40 locationsNCT06365853
Recruiting
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Healthcare associated infectionsPneumonia, Ventilator-AssociatedPneumonia Neonatal
Biobizkaia Health Research Institute1,500 enrolled39 locationsNCT07240038